z-logo
open-access-imgOpen Access
BRCA2 Reversion Mutation Identified by Liquid Biopsy After Durable Response to FOLFIRINOX in BRCA2-Associated Pancreatic Cancer
Author(s) -
Tomohiro Kondo,
Masashi Kanai,
Junichi Matsubara,
Pham Nguyen Quy,
Keita Fukuyama,
Yoshihiro Yamamoto,
Takahiro Yamada,
Masakazu Nishigaki,
Sachiko Minamiguchi,
Masayuki Takeda,
Kenji Nishio,
Shigemi Matsumoto,
Manabu Muto
Publication year - 2020
Publication title -
pancreas
Language(s) - English
Resource type - Journals
eISSN - 1536-4828
pISSN - 0885-3177
DOI - 10.1097/mpa.0000000000001672
Subject(s) - medicine , folfirinox , gemcitabine , oncology , pancreatic cancer , oxaliplatin , olaparib , breast cancer , irinotecan , epirubicin , chemotherapy , chemoradiotherapy , cancer , cancer research , colorectal cancer , poly adp ribose polymerase , biology , biochemistry , polymerase , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here